Embolotherapy Market Growth, Development and Demand Forecast Report, 2030

The National Cancer Institute, under the U.S. Department of Health and Human Services, states that 76,080 new cases of kidney and renal pelvic cancer were diagnosed in the U.S. in 2021. Further, the Brain Aneurysm Foundation estimates that over 30,000 people suffer a brain aneurysm rupture every year in the U.S. Likewise, Brain Foundation of Migraine and Headache Australia states that approximately more than 2% of adults suffer from aneurysms and 10% of these adults live with multiple aneurysms.

Thus, the expanding patient pool of aneurysms, renal cell carcinoma (RCC), and varicose veins will help the embolotherapy market display a CAGR of 7.7% during 2020-2030. According to P&S Intelligence, the market revenue stood at $3,082.9 million in 2020, and it will reach $6,447.1 million by 2030. Additionally, the rising incidence of chronic and lifestyle-associated diseases will also propel the requirement for embolotherapy products and procedures in the forthcoming years. For example, the World Health Organization (WHO) states that approximately 10 million cancer-related deaths were recorded in 2020.

Browse full report at: https://www.psmarketresearch.com/market-analysis/embolotherapy-market

Embolotherapy products, such as embolic agents and support devices, are used to indicate cancers, gastrointestinal diseases, peripheral vascular diseases, urological and nephrological disorders, and neurological diseases. In the last few years, embolic agents were preferred over support devices as embolic agents, such as radioactive yttrium-90 (Y-90) microspheres, calibrated microspheres for bland embolization, and drug-eluting microspheres, have been extremely successful in treating primary or secondary liver disease. Additionally, the medical fraternity also uses embolic agents like embolic coils, detachable balloons, liquid embolic agents, and embolic plug systems to indicate such diseases.

In addition to embolotherapy products, embolotherapy procedures, such as transcatheter arterial embolization (TAE), transarterial chemoembolization (TACE), and transarterial radioembolization (TARE)/selective Internal radiation therapy (SIRT), are also used to indicate chronic diseases. In the coming years, healthcare facilities will reflect a high inclination toward TAE due to the soaring geriatric population and burgeoning need for minimally invasive procedures. As compared to TARE/SIRT and TACE, TAE is more effective and better-tolerated in patients with ruptured hepatocellular carcinoma (HCC).

In recent years, companies offering embolotherapy products and procedures have engaged in product launches and regulatory approvals to cater to the needs of ambulatory surgical centers (ASCs) and hospitals and clinics. For instance, in January 2019, Terumo Europe received the CE mark for QuiremScout, which is designed to improve the SIRT workup procedure by enhancing the accuracy of predicting intrahepatic distribution and lung shunting, to maximize SIRT patient selection and treatment planning. This product will be exclusively distributed by Terumo in Europe.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/embolotherapy-market/report-sample

Geographically, the North American region dominated the embolotherapy market in the preceding years, and it is expected to retain its dominance in the foreseeable future as well. This lead can be attributed to the growing prevalence of indications that need embolization procedures and the booming geriatric population in the region. Moreover, the presence of an established healthcare ecosystem and large-scale development of improved embolic agents will also result in the widescale adoption of embolotherapy products and procedures in Canada and the U.S.

Thus, the growing patient pool and soaring cases of lifestyle-associated and chronic diseases will augment the requirement for embolotherapy procedures and products in the upcoming years.

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

This release was published on openPR.